Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-02-08
2005-02-08
Gambel, Phillip (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C530S350000
Reexamination Certificate
active
06852497
ABSTRACT:
The invention provides isolated nucleic acids molecules, designated SLIC-1 nucleic acid molecules, which encode novel P-selectin glycoprotein ligand (PSGL-1) binding molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing SLIC-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a SLIC-1 gene has been introduced or disrupted. The invention still further provides isolated SLIC-1 proteins, fusion proteins, antigenic peptides and anti-SLIC-1 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
REFERENCES:
patent: 5843707 (1998-12-01), Larsen et al.
patent: WO 9410309 (1994-05-01), None
patent: WO 0058473 (2000-10-01), None
Insug et al. Peptide 23: 999-1010, 2002.*
Blanck et al. J. Biol. Chem. 271: 7289-7292, 1996.*
Kogan et al. J. Biol Chem. 270: 14047-14055, 1995.*
Structure and Mechanism in Protein Science Alan Fersht (ED) W.H. Freeman and Company N.Y. pp. 33-34.*
Kricka (ED) Ligand-Binder Assays Marcel Dekker, Inc. NY pp. 1-3.*
Skolnick et al. Trends in Biotechnologh 18: 34-39, 2000.*
Ngo et al. In The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al.(ED) Birkhauser, Boston MA pp. 433, 492-495.*
Kuntz Science 257: 1078-1082, 1992.*
Alonso-Lebrero, J.L., et al., “Polarization and interaction of adhesion molecules P-selectin glycoprotein ligand 1 and intercellular adhesion molecule 3 with moesin and ezrin in myeloid cells,”Blood,vol. 95, No. 7:2413-2419, Apr. 1, 2000.
Sako, Dianne, et al., “Expression Cloning of a Functional Glycoprotein Ligand for P-Selectin,”Cell,vol. 75: 1179-1186, Dec. 17, 1993.
Snapp, K.R., et al., “The cytoplasmic tail of P-selectin glycoprotein ligand-1 (PSGL-1) is required for optimal interactions with P-selectin”FASEB Journal,vol. 14, No. 6:A1146, Apr. 20, 2000 XP002186365.
XP002186366 Abstract Database EMBL [Online] HS1186915, accession No. AA282390, Apr. 4, 1997.
XP002186367 Abstract Database EMBL [Online] accession No. AW134842, Oct. 29, 1999.
XP002186368 Abstract Database EMBL [Online] accession No. AC007608, May 21, 1999.
Bevilacqua, M. P. et aaaaal., “Selectins,”J. Clin. Invest.91(2):379-87 (1993) retrieved from Internet on Mar. 21, 2000 at gateway.ovid.com.
Evangelista V. et al., “Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule,”Blood,Feb. 1, 1999;93(3):876-85.
Gyuris, J. et al., “Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2,”CellNov. 19, 1993;75(4):791-803.
Harris, E.S. et al., “A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by beta1 and beta2 integrins,”BloodFeb. 1, 2001;97(3):767-76.
Hildt, E. et al., “Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I,”J. Exp. Med.,Jun. 7, 1999;189(11):1707-14.
Hidari, K. I.-P.J. et al., “Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils,” J. Biol. Chem., Nov. 7, 1997;272(45):28750-6.
Lowe, J.B. et al., “Therapeutic inhibition of carbohydrate-protein interactions in vivo,”J. Clin. Invest.,99(5):822-26 (1997) retrieved from Internet on Mar. 21, 2000 at http://gateway.ovid.com.
McEver, R.P. et al., “Role of PSGL-1 binding to selectins in leukocyte recruitment,”J. Clin. Invest.100(3):485-91 (1997) retrieved from Internet on Mar. 20, 2000 at gateway.ovid.com.
Sako, D. C. et al., “Expression cloning of a functional glycoprotein ligand for P-selectin,”Cell,Dec. 17, 1993;75(6):1179-86.
Schievella, A. et al., “MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase,”J. Biol. Chem.,May 2, 1997;272(18):12069-75.
Varki, A., “Selectin ligands: Will the real ones please stand up”J. Clin. Invest.,99(2):158-62 (1997) retrieved from Internet on Mar. 21, 2000 at gateway.ovid.com.
Kriz Ron
Lorenz Meike
Shaw Gray D.
Weich Nadine
Finnegan Henderson Farabow Garrett & Dunner LLP
Gambel Phillip
Genetics Institute LLC
LandOfFree
Methods of identifying compounds which inhibit binding of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of identifying compounds which inhibit binding of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying compounds which inhibit binding of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3494856